Epigenetics Market to Reach $3.92 Billion by 2031 as Drug Discovery Drives 12% CAGR
Updated
Updated · PR Newswire · Jun 26
Epigenetics Market to Reach $3.92 Billion by 2031 as Drug Discovery Drives 12% CAGR
3 articles · Updated · PR Newswire · Jun 26
Summary
$3.92 billion is the projected size of the global epigenetics market in 2031, up from $2.22 billion in 2026, according to a MarketsandMarkets forecast.
Drug discovery, oncology research, precision medicine and biomarker development are driving adoption of epigenomic tools, with demand rising for high-throughput profiling and AI-enabled data analysis.
Kits and reagents held the largest product share in 2025, reflecting recurring use across methylation, chromatin and sequencing workflows; next-generation sequencing led the technology segment.
DNA methylation accounted for 56.2% of the market in 2025, academic and research institutes made up 45.9% of end-user demand, and North America led regions with a 41.7% share.